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AB S T R A CT  
One of the serious complications associated with diabetes is foot ulcer and this condition affects the quality of 
life in patients in all classes, races and ages. Chronic wounds are prone to colonization by wide array of 
microorganisms which could be extremely hazardous to patients if effective and timely therapeutic intervention 
is not made. This study was conducted to determine the antibiotic susceptibility profiles of bacteria from diabetic 
foot infections in southwestern Nigeria. Samples were collected from a total of 142 diabetic foot ulcer patients 
with moistened sterile cotton swabs. Nutrient agar, Mac-Conkey agar, blood agar and mannitol salt agar media 
were used for the isolation of total viable bacteria, Gram-negative non-spore forming lactose fermenters, 
fastidious bacteria and staphylococci, respectively. Morphological and biochemical characteristics of pure 
cultures were determined in accordance with standard laboratory criteria. API 20 E and API 20 NE were used 
for the confirmation of identity of the bacterial isolates. The disc diffusion technique was employed for the 
determination of antibiotic susceptibility of bacterial isolates in accordance with standard procedures. The 
antibiotics investigated included amikacin, amoxicillin, ampicillin, ceftazidime, cefazolin, ceftriaxone, 
chloramphenicol, ciprofloxacin, clindamycin, gentamicin, imipenem, linezolid, methicillin, netilmicin, ofloxacin, 
oxacillin, penicillin, piperacilin, sulfamethoxazole, trimethoprim and vancomycin. One hundred and seventy-
seven isolates were encountered and these were characterized into eleven bacterial species. These included 
Staphylococcus aureus (22.03%), Pseudomonas aeruginosa (16.95%), Staphylococcus epidermidis (12.43%), Proteus mirabilis 
(8.48%), Klebsiella pneumoniae (7.91%), E. coli (7.35%), Staphylococcus saprophyticus (6.78%), Streptococcus pyogenes 
(5.65%), Morganella morganii (5.09%), Citrobacter freundii (4.52%) and Acinetobacter baumannii (2.83%). Gram-negative 
bacteria showed 76.99% susceptibility to the antibiotics while 22.85% was resistant. Gram-positive bacteria 
showed 93.75% susceptibility and 5.01% resistance to the antibiotics. This study revealed that there is no definite 
aetiologic bacterial agent for diabetic foot infections and many of the associated bacteria are sensitive to certain 
antibiotics. 
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1 Introduction 
Diabetes mellitus represents a major public health 
threat worldwide with an estimated prevalence in 
2014 of 422 million patients [1]. A serious 
complication of diabetes is the development of foot 
ulcers. World Health Organization (WHO) 
considered diabetes as one of the twentieth-century 
epidemics and the most prevalent endocrine disease 
worldwide with about 10% of global adult population 
standing the risk of being affected [2]. This disease 
condition is associated with severe secondary and 
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highly impairing pathologies which include vascular 
disease with high risk for heart failure and stroke, 
kidney failure requiring dialysis or transplantation, 
and blindness. The most devastating conditions in 
these patients include chronic wounds caused by an 
impaired immune response and an associated high 
microbial burden that frequently leads to amputation, 
mainly of the lower limbs [2], [3].  Every individual is 
prone to securing skin lesions during a lifetime and 
which usually heal up without any special care or 
treatment, but a simple tiny scratch could become a 
terrible condition for diabetic patients. The lesion 
could graduate into seriously infected chronic wound 
leading to amputation or even death [4], [5]. A 
contributing factor usually is skin microbiota of 
diabetic patients [6] - [10].  
Naturally healing of diabetic chronic wounds is 
difficult and this makes some degree of therapeutic 
intervention imperative [11]. Corresponding clinical 
treatments are usually initiated after diagnosis of the 
wound chronic stage. Compromised tissues 
debridement, use of specialized dressings, and 
appropriate use of antibiotics are the most frequently 
used approaches to combating diabetic chronic 
wounds [12]. Success rates are, however, still not 
satisfactory as no significant improvement has been 
reported in more than fifty-percent of the patients to 
this approach. Hence, hospitalization and amputation 
were often the resulting outcome [2], [13], [14]. 
Inappropriate antibiotic administration could further 
impair wound healing progression in many patients 
[15], [16], and as physicians were left with no options, 
persistent administration systemic antibiotics 
becomes the order of the day [12], with the hope that 
something changes in the health condition of the 
patient that allows the wound to enter a remission 
stage [11]. There is no doubt that this is a life-
threatening problem which requires urgent 
chemotherapeutic interventions, hence the need to 
relentlessly determine the sensitivity of associated 
microorganisms to conventional antibiotics. Based on 
the severity and risk associated with foot ulcers, and 
variations of reports among different geographical 
places and periods, it becomes imperative to 
characterize and determine the antibiotic 
susceptibility patterns of the bacteria from diabetic 
foot infections in southwestern Nigeria.  
Based on the severity and risk associated with foot 
ulcers, and variations of reports among different 
geographical places and periods, it becomes 
imperative to characterize and determine the 
antibiotic susceptibility patterns of the bacteria from 
diabetic foot infections in southwestern Nigeria.  
2 Materials and Methods  
2.1 Collection of Samples 
Ethical clearances were obtained from the 
institutional ethical committees before collection of 
samples. Samples (pus, wound exudates) collections 
were undertaken in medical wards between October, 
2016 and March, 2017.  Wounds were washed 
vigorously with normal saline solution and discharges 
from margins and edges of ulcer were collected from 
a total of 142 patients (105 in-patients and 37 out-
patients). Sixty-seven (67) samples were obtained 
from University College Hospital (UCH), Ibadan 
while 75 samples were obtained from Olabisi 
Onabanjo University Teaching Hospital (OOUTH), 
Sagamu. Samples were collected with sterile cotton 
swabs already moistened with sterile saline to prevent 
drying. The swabs were transported to the laboratory 
in sterile containers immediately after collection. 
Samples which were not analyzed within four hours 
of collection were discarded.  
2.2 Microbiological Analysis 
Swabs were separately inoculated on appropriate agar 
media for cultivation and enumeration of associated 
bacteria. Nutrient agar (Oxoid, England), Mac-
Conkey agar (Oxoid, England), blood agar (Oxoid, 
England) and mannitol salt agar (Oxoid, England) 
media were used for the isolation of total viable 
bacteria, Gram-negative non-spore forming lactose 
fermenters, fastidious bacteria and staphylococci, 
respectively. The inoculated plates were incubated at 
37oC for 24 hours. Plates with mixed cultures were 
sub-cultured to obtain pure colonies of bacteria. 
Morphological and biochemical characteristics of the 
discreet colonies were determined in accordance with 
standard laboratory criteria. The tests performed 
include Gram staining, motility, catalase, oxidase, 
indole, methyl-red, VogesProskauer, urease, citrate 
utilization, starch hydrolysis, nitrate reduction and 
sugar fermentation test using glucose, sucrose, 
arabinose, maltose, xylose, galactose, sorbitol, 
invositol, raffinose and frauction while API 20 E and 
API 20 NE were used for the confirmation of identity 
of the bacterial isolates. 
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2.3 Antibiotic Susceptibility Test 
2.3.1 Standardization of Inoculum  
Cultures of bacteria were cultivated on nutrient agar 
(Oxoid, England) plates and plates incubated for 24 
hours at 37oC. About 100 µl of bacterial cells was 
dispensed in sterile normal saline to obtain the 
turbidity of 0.5 McFarland standard, which is a 
solution of barium sulphate prepared from 0.6 ml of 
1% barium chloride added to 99.4 ml of sulphuric 
acid [17], [18].  
2.3.2 Sensitivity Assay 
The disc diffusion technique was employed for the 
determination of antibiotic susceptibility of bacterial 
isolates in accordance with standard procedures. 
Young actively growing cultures of bacteria were 
obtained on nutrient agar (Oxoid, England) plates 
by overnight incubation at 37oC. Muller Hinton agar 
(Oxoid, England) media was prepared in sterile Petri 
dishes. Sterilized swabs were dipped in overnight 
cultures and spread evenly over the media. The 
various antibiotic discs were aseptically placed over 
the media and incubated overnight at 37°C. The 
conventional antibiotics investigated in this study 
included amikacin (30 µg), amoxicillin (30 µg), 
ampicillin (10 µg), ceftazidime (30 µg), cefazolin (30 
µg), ceftriaxone (30 µg), chloramphenicol (30 µg), 
ciprofloxacin (5 µg),clindamycin (2 µg), gentamicin 
(10 µg), imipenem (10 µg), linezolid (30 µg), 
methicillin  (5 µg), netilmicin (30 µg), ofloxacin (5 
µg), oxacillin (2 µg), penicillin (10 µg), piperacilin 
(100 µg), sulfamethoxazole (25 µg), trimethoprim (5 
µg) and vancomycin (30 µg) [18].  
3 Results and Discussion 
A total of 142 samples, comprising of 105 in-patients 
and 37 out-patients, were collected. Out of the total 
samples, 75 (56 in-patients and 19 out-patients) were 
collected from UCH, Ibadan while 67 (49 in-patients 
and 18 out-patients) were obtained from OOUTH, 
Sagamu (Table 1). Table 2 showed the occurrence of 
bacteria among diabetic foot ulcer in- and out-
patients visiting teaching hospitals in southwestern 
Nigeria. The organisms were distributed between the 
in-patients and out-patients visiting the teaching 
hospitals. Invariably, both the in-patients and out-
patients contributed to the bacterial diversity 
encountered in this study. Table 3 showed the 
morphological and biochemical characteristics of 
bacteria isolated from diabetic foot ulcer in selected 
visiting hospitals in southwestern Nigeria. A total of 
one hundred and seventy-seven (177) isolates were 
encountered in this study and these were 
characterized as eleven (11) bacterial species. They 
were Acinetobacter baumannii, Citrobacter freundii, 
Escherichia coli, Klebsiella pneumoniae, Morganella morganii, 
Proteus mirabilis, Pseudomonas aeruginosa, Staphylococcus 
aureus, Staphylococcus epidermidis, Staphylococcus 
saprophyticus and Streptococcus pyogenes.  
Table 1: Details of sample collection from patients 
from selected teaching hospitals in southwestern 
Nigeria 
Sampling Site In-
patient 
Out-
patient 
Total 
Number of 
Samples 
UCH, Ibadan 56 19 75 
OOUTH, 
Sagamu 
49 18 67 
Total 105 37 142 
 
Table 2: Occurrence of bacteria among diabetic foot 
ulcer in- and out-patients visiting teaching hospitals in 
southwestern Nigeria 
Bacteria In-
patient 
Out-
patient 
Total 
number of 
bacteria 
Acinetobacter 
baumannii 
4 1 5 
Citrobacter freundii 5 3 8 
Escherichia coli 9 4 13 
Klebsiella pneumonia 9 5 14 
Morganella morganii 7 2 9 
Proteus mirabilis 11 4 15 
Pseudomonas 
aeruginosa 
23 7 30 
Staphylococcus aureus 30 9 39 
Staphylococcus 
epidermidis 
17 5 22 
Staphylococcus 
saprophyticus 
9 3 12 
Streptococcus 
pyogenes 
6 4 10 
Total 130 47 177 
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Table 3: Morphological and biochemical characteristics of bacteria isolated from diabetic foot ulcer patients visiting 
teaching hospitals in southwestern Nigeria 
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Most Probable 
Identity 
-ve Cb + - - - - - + + - - - - - + - - - - + - - - - - 5 
Acinetobacter 
baumannii 
+ve R + + + + + - - + - - - - - + + - + + - - + - + + 8 
Citrobacter 
freundii 
-ve R - + - + + + - + - - + + + + + + - + + - - - - + 13 Escherichia coli 
-ve R + - - - - + + + + + + - + + + + + + + - - + - + 14 K. pneumoniae 
-ve R + - + + + - + - - - - - + + - - - - + + - - - - 9 
Morganella 
morganii 
-ve R + + - + - + + + - + - - + + + + + + + + - - + + 15 P.  aeruginosa 
-ve R + - - + + - + + + - - - + + - - - - + - - - - - 30 Proteus mirabilis 
+ve C + - - - - + + - - + + - + + + - + + - + - - - + 39 S. aureus 
+ve C + - - - - + + - - + - - - + + - - - - - - - - + 22 S. epidermidis 
+ve C + - - - - + + - - + + - + + + - + + - + - - - + 12 S. saprophyticus 
+ve C - - - - + + + + - + + + - + + - + - - + - - - - 10 
Streptococcus 
pyogenes 
 
Keys: Cb = Coccobacilli; R = Rods; C = Cocci; + = Positive reaction; - = Negative reaction; ND = Not determined 
 
The percentage occurrences of bacteria isolated from 
diabetic foot ulcer in-patients and out-patients were 
shown in Figure 1. Staphylococcus aureus had the highest 
percentage occurrence of 23.08% and 19.15% in in-
patients and out-patients, respectively. This was 
followed by P. aeruginosa with 17.69% (in-patient) and 
14.89% (out-patients). Among the in-patients, S. 
epidermidis had the next percentage occurrence of 
13.08%, followed by Proteus mirabilis (8.46%), E. coli 
(6.92%), S. saprophyticus (6.92%), Morganella morganii 
(5.39%), Streptococcus pyogenes (4.62%), C. freundii 
(3.85%) while Acinetobacter baumannii had the lowest 
occurrence of 3.08%. However, among the out-
patients, Acinetobacter baumannii with percentage 
occurrence of 12.13% was next to P. aeruginosa 
(14.89%) while K. pneumoniae, S. epidermidis, E. coli, S. 
pyogenes, C. freundii and M. morganii had percentage 
occurrences of   10.64%, 10.64%, 8.51%, 8.51%, 
6.38% and 4.25%, respectively. 
The overall percentage occurrences of the bacterial 
species associated with diabetic foot ulcers was shown 
in Figure 2. S. aureus had the highest occurrence of 
22.03%, followed by P. aeruginosa (16.95%), S. 
epidermidis (12.43%), P. mirabilis (8.48%), K. pneumoniae 
(7.91%), E. coli (7.35%), S. saprophyticus (6.78%), S. 
pyogenes (5.65%), M. morganii (5.09%), C. freundii 
(4.52%) while A. baumannii (2.83%) had the lowest 
occurrence. Percentage occurrence of Gram-positive 
and Gram-negative bacteria in diabetic foot ulcers 
was given in Figure 3. Results showed that there were 
a greater number of Gram-negative bacteria than 
Gram-positive bacteria associated with diabetic foot 
ulcers investigated in this study. The percentage 
occurrence of Gram-negative bacteria was 53% while 
that of Gram-positive bacteria was 47%.  
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Figure 1: Percentage occurrence of bacteria isolated from diabetic foot ulcer in-patients and out-patients visiting 
teaching hospitals in southwestern Nigeria 
 
 
 
 
Figure 2: Overall percentage occurrence of bacteria associated with diabetic foot ulcer from patients visiting teaching 
hospitals in southwestern Nigeria 
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Figure 3: Percentage occurrence of Gram-positive and 
Gram-negative bacteria in diabetic foot ulcers from 
selected visiting hospitals in southwestern Nigeria 
 
Tables 4a and 4b showed the antibiotic susceptibility 
and resistance profiles of Gram-negative bacteria 
isolated from diabetic foot ulcers. Generally, most 
strains of Gram-negative bacterial species 
encountered in this study were susceptible to many of 
the antibiotics investigated. Acinetobacter baumannii 
showed 100% susceptibility to amikacin, amoxicillin, 
ampicillin, ceftazidime, ceftriaxone, clindamycin, 
imipenem, methicillin and piperacilin 40%, 20%, 60% 
and 60% resistances were shown to chloramphenicol, 
gentamycin, netilmicin and ofloxacin, respectively. C. 
freundii showed 100% sensitivity to amikacin, 
ceftazidime, cefazolin, ceftriaxone, chloramphenicol, 
clindamycin, gentamycin, imipenem, methicillin, 
ofloxacin and piperacillin while 62.5%, 37.5% and 
37.5% resistances were shown to amoxicillin, 
ampicillin and netilmicin, respectively. E. coli strains 
showed 100%, 84.6%, 84.6%, 15.4% and 15.4% 
resistances to amoxicillin, ampicillin, cefazolin, 
methicillin and netilmicin, respectively while 100% 
susceptibility was shown to other antibiotics except 
amikacin to which 92.3% sensitivity and 7.7% 
intermediate sensitivity were shown. All strains of K. 
pneumoniae isolated were sensitive to amikacin, 
ceftazidime, ceftriaxone, clindamycin, gentamycin, 
imipenem, ofloxacin and piperacillin while all strains 
were resistant to amoxicillin and ampicillin. However, 
64.3%, 21.4%, 28.6% and 28.6% of strains exhibited 
resistance to cefazolin, chloramphenicol, methicillin 
and netilmicin, respectively. All M. morganii strains 
were sensitive to all antibiotics except amoxicillin and 
ampicillin to which 22.2% and 44.4%, resistances 
were shown respectively.  
P. mirabilis exhibited 100% susceptibility to amikacin, 
ceftazidime, ceftriaxone, clindamycin, gentamycin, 
imipenem, methicillin, netilmicin, ofloxacin and 
piperacillin while strains showed 100% resistance to 
amoxicillin and ampicillin. However, the strains of 
organism exhibited 26.7%, 13.3% and 20% to 
cefazolin, chloramphenicol and nitilmicin, 
respectively. P. aeruginosa strains showed 100% 
resistance to amoxicillin and ampicillin; 13.3%, 
63.3%, 60%, 23.3%, 30%, 23.3% and 73.3% 
resistances were exhibited to amikacin, cefazolin, 
chloramphenicol, clindamycin, gentamycin, 
methicillin and netilmicin, respectively. 
The antibiotic susceptibility and resistance profiles of 
Gram-positive bacteria isolated from diabetic foot 
ulcers were shown in Tables 5a and 5b. All S. aureus 
strains were sensitive to amikacin, amoxicillin, 
ampicillin, ceftriaxone, imipenem, linezolid, 
netilmicin, ofloxacin, penicillin, piperacillin, 
sulphamethazole and trimethoprim; strains showed 
71.8% sensitivity and 28.2% intermediate sensitivity 
to vancomycin while 12.8%, 20.5%, 28.2% and 15.5% 
resistances were exhibited to ceftazidime, cefazolin, 
ciprofloxacin and gentamycin, respectively.  
S. epidermidis strains showed 27.3%, 9.1%, 18.2% and 
59.1% resistances to ampicillin, ceftazidime, penicillin 
and vancomycin, respectively while strains exhibited 
100% sensitivity to other antibiotics. Strains of S. 
saprophyticus exhibited 25%, 16.7% and 66.7% 
resistances to penicillin, piperacillin and vancomycin, 
respectively; strains exhibited intermediate 
susceptibilities of 8.3%, 16.7% and 16.7% to 
ceftazidime, gentamycin and vancomycin, 
respectively while 100% susceptibility was shown to 
the remaining antibiotics. Strains of S. pyogenes were 
sensitive to all antibiotics except ampicillin, netilmicin 
and penicillin to which 30%, 10% and 30% 
resistances were shown, respectively while 20% of 
strains showed intermediate susceptibility to 
vancomycin. 
Gram-negative 
bacteria, 53%
Gram-positive 
bacteria, 47%
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Table 4a:  Antibiotic susceptibility and resistance profiles of Gram-negative bacteria isolated from diabetic foot ulcer 
patients visiting selected visiting hospitals in southwestern Nigeria 
Bacteria  Amikacin Amoxicillin Ampicillin Ceftazidime Cefazolin Ceftriaxone Chloram-
phenicol 
Acinetobacter 
baumannii 
(n = 5) 
S 5 
100% 
5 
100% 
5 
100% 
5 
100% 
5 
100% 
5 
100% 
3 
60% 
I 0 0 0 0 0 0 0 
R 0 0 0 0 0 0 2 
40% 
Citrobacter freundii 
(n = 8) 
S 8 
100% 
3 
37.5% 
5 
62.5% 
8 
100% 
8 
100% 
8 
100% 
8 
100% 
I 0 0 0 0 0 0 0 
R 0 5 
62.5% 
3 
37.5% 
0 0 0 0 
Escherichia coli 
(n = 13) 
S 12 
92.3% 
0 2 
15.4% 
13 
100% 
2 
15.4% 
13 
100% 
13 
100% 
I 1 
7.7% 
0 0 0 0 0 0 
R 0 13 
100% 
11 
84.6% 
0 11 
84.6% 
0 0 
Klebsiella 
pneumoniae 
(n = 14) 
S 14 
100% 
0 0 14 
100% 
5 
35.7% 
14 
100% 
11 
78.6% 
I 0 0 0 0 0 0 0 
R 0 14 
100% 
14 
100% 
0 9 
64.3% 
0 3 
21.4% 
Morganella 
morganii 
(n = 9) 
S 9 
100% 
7 
77.8 
5 
55.6% 
9 
100% 
9 
100% 
9 
100% 
9 
100% 
I 0 0 0 0 0 0 0 
R 0 2 
22.2% 
4 
44.4% 
0 0 0 0 
Proteus mirabilis 
(n = 15) 
S 15 
100% 
0 0 15 
100% 
11 
73.3% 
15 
100% 
13 
86.7% 
I 0 0 0 0 0 0 0 
R 0 15 
100% 
15 
100% 
0 4 
26.7% 
0 2 
13.3% 
Pseudomonas 
aeruginosa 
(n = 30) 
S 25 
83.3% 
0 0 30 
100% 
11 
36.7% 
30 
100% 
12 
40% 
I 1 
3.3% 
0 0 0 0 0 0 
R 4 
13.3% 
30 
100% 
30 
100% 
0 19 
63.3% 
0 18 
60% 
Keys: S = Susceptible or Sensitive; I = Intermediately Susceptible/Sensitive and R = Resistant 
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Table 4b:  Antibiotic susceptibility and resistance profiles of Gram-negative bacteria isolated from diabetic foot ulcer 
patients visiting selected visiting hospitals in southwestern Nigeria 
Bacteria  Clindamycin Gentamycin Imipenem Methicillin Netilmicin Ofloxacin Piperacilin 
Acinetobacter 
baumannii 
(n = 5) 
S 5 
100% 
4 
80% 
5 
100% 
5 
100% 
2 
40% 
2 
40% 
5 
100% 
I 0 0 0 0 0 0 0 
R 0 1 
20% 
0 0 3 
60% 
3 
60% 
0 
Citrobacter freundii 
(n = 8) 
S 8 
100% 
8 
100% 
8 
100% 
8 
100% 
5 
62.5% 
8 
100% 
8 
100% 
I 0 0 0 0 0 0 0 
R 0 0 0 0 3 
37.5% 
0 0 
Escherichia coli 
(n = 13) 
S 13 
100% 
13 
100% 
13 
100% 
11 
84.6% 
11 
84.6% 
13 
100% 
13 
100% 
I 0 0 0 0 0 0 0 
R 0 0 0 2 
15.4% 
2 
15.4% 
0 0 
Klebsiella 
pneumoniae 
(n = 14) 
S 14 
100% 
14 
100% 
14 
100% 
10 
71.4% 
10 
71.4% 
14 
100% 
14 
100% 
I 0 0 0 0 0 0 0 
R 0 0 0 4 
28.6% 
4 
28.6% 
0 0 
Morganella 
morganii 
(n = 9) 
S 9 
100% 
9 
100% 
9 
100% 
9 
100% 
9 
100% 
9 
100% 
9 
100% 
I 0 0 0 0 0 0 0 
R 0 0 0 0 0 0 0 
Proteus mirabilis 
(n = 15) 
S 15 
100% 
15 
100% 
15 
100% 
15 
100% 
12 
80% 
15 
100% 
15 
100% 
I 0 0 0 0 0 0 0 
R 0 0 0 0 3 
20% 
0 0 
Pseudomonas 
aeruginosa 
(n = 30) 
S 23 
76.7% 
21 
70% 
30 
100% 
23 
76.7% 
8 
26.7% 
30 
100% 
30 
100% 
I 0 0 0 0 0 0 0 
R 7 
23.3% 
9 
30% 
0 7 
23.3% 
22 
73.3% 
0 0 
Keys: S = Susceptible or Sensitive; I = Intermediately Susceptible/Sensitive and R = Resistant 
Table 5a:  Antibiotic susceptibility and resistance profiles of Gram-positive bacteria isolated from diabetic foot ulcer 
patients visiting selected visiting hospitals in southwestern Nigeria 
Bacteria  Ami- 
kacin 
Amoxi-
cillin 
Ampi-
cillin 
Cefta-
zidime 
Cefa-zolin Ceftria-
xone 
Cipro-
floxacin 
Genta-
mycin 
Imipenam 
S. aureus 
(n = 39) 
S 39 
100% 
39 
100% 
39 
100% 
34 
87.2% 
31 
79.5% 
39 
100% 
28 
71.8% 
33 
84.6% 
39 
100% 
I 0 0 0 0 0 0 0 0 0 
R 0 0 0 5 
12.8% 
8 
20.5% 
0 11 
28.2% 
6 
15.5% 
0 
S. epidermidis 
(n = 22) 
S 22 
100% 
22 
100% 
16 
72.7% 
20 
90.9% 
22 
100% 
22 
100% 
22 
100% 
22 
100% 
22 
100% 
I 0 0 0 0 0 0 0 0 0 
R 0 0 6 
27.3% 
2 
9.1% 
0 0 0 0 0 
S. saprophyticus 
(n = 12) 
S 12 
100% 
12 
100% 
12 
100% 
11 
91.7% 
12 
100% 
12 
100% 
12 
100% 
10 
83.3% 
12 
100% 
I 0 0 0 1 
8.3% 
0 0 0 2 
16.7% 
0 
R 0 0 0 0 0 0 0 0 0 
S. pyogenes 
(n = 10) 
S 10 
100% 
10 
100% 
7 
70% 
10 
100% 
10 
100% 
10 
100% 
10 
100% 
10 
100% 
10 
100% 
I 0 0 0 0 0 0 0 0 0 
R 0 0 3 
30% 
0 0 0 0 0 0 
Keys: S = Susceptible or Sensitive; I = Intermediately Susceptible/Sensitive and R = Resistant 
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Table 5b:  Antibiotic susceptibility and resistance profiles of Gram-positive bacteria isolated from diabetic foot ulcer 
patients visiting selected visiting hospitals in southwestern Nigeria 
Bacteria  Line-
zolid 
Netil-
micin 
Oflo-
xacin 
Oxa-
cillin 
Peni-
cillin  
Pipera-cilin Sulpha-
methazole  
Trime-
thoprim   
Vanco-
mycin 
S. aureus 
(n = 39) 
S 39 
100% 
39 
100% 
39 
100% 
34 
87.2% 
39 
100% 
39 
100% 
39 
100% 
39 
100% 
28 
71.8% 
I 0 0 0 0 0 0 0 0 11 
28.2% 
R 0 0 0 5 0 0 0 0 0 
S. epidermidis 
(n = 22) 
S 22 
100% 
22 
100% 
22 
100% 
22 
100% 
18 
81.8% 
22 
100% 
22 
100% 
22 
100% 
9 
40.9% 
I 0 0 0 0 0 0 0 0 0 
R 0 0 0 0 4 
18.2% 
0 0 0 13 
59.1% 
S. saprophyticus 
(n = 12) 
S 12 
100% 
12 
100% 
12 
100% 
12 
100% 
9 
66.7% 
10 
83.3% 
12 
100% 
12 
100% 
2 
16.7% 
I 0 0 0 0 0 0 0 0 2 
16.7% 
R 0 0 0 0 3 
25% 
2 
16.7% 
0 0 8 
66.7% 
S. pyogenes 
(n = 10) 
S 10 
100% 
9 
90% 
10 
100% 
10 
100% 
7 
70% 
10 
100% 
10 
100% 
10 
100% 
8 
80% 
I 0 0 0 0 0 0 0 0 2 
20% 
R 0 1 
10% 
0 0 3 
30% 
0 0 0 0 
 
Keys: S = Susceptible or Sensitive; I = Intermediately Susceptible/Sensitive and R = Resistant 
Table 6: CLSI interpretive performance standard for antimicrobial disk susceptibility testing [18] 
Antibiotic Conc. (µg) S I R 
Amikacin 30 ≥ 17 15–16 ≤ 14 
Amoxicillin 30  17 - ≤ 16 
Ampicillin 10 ≥ 17 - ≤ 16 
Ceftazidime 30  21 18-20 ≤ 17 
Cefazolin 30  15 - ≤ 14 
Ceftriaxone  30 ≥ 23 20–22 ≤ 19 
Chloramphenicol 30  18 13-17 ≤ 12 
Ciprofloxacin 5 ≥ 21 16–20 ≤ 15 
Clindamycin 2  21 15-20 ≤ 14 
Gentamicin 10 ≥ 15 13–14 ≤ 12 
Imipenem 10  23 20-22 ≤ 19 
Linezolid 30  21 - ≤ 20 
Methicillin 5  19 16-18 ≤ 15 
Netilmicin 30  15 13-14 ≤ 12 
Ofloxacin  5 ≥ 16 13–15 ≤ 12 
Oxacillin 2  22 - ≤ 21 
Penicillin 10  15 - ≤14 
Piperacilin 100 ≥ 21 18-20 ≤ 17 
Sulfamethoxazole 25  30 26-29 ≤ 25 
Trimethoprim 5  16 11-15 ≤ 10 
Vancomycin 30  17 15–16  14 
10 
 
ISSN: 2456-7132 
Available online at Journals.aijr.in 
Antibiotic Susceptibility Profiles of Bacteria from Diabetic Foot Infections in Selected Teaching Hospitals in Southwestern Nigeria 
 
Figure 4 showed the percentage susceptibility and 
resistance of Gram-negative bacteria isolated from 
diabetic foot ulcers to antibiotics. A high percentage 
(76.99%) of Gram-negative bacteria isolated was 
susceptible to the conventional antibiotics under 
study while 22.85% was resistant and a low 
percentage (0.15%) showed intermediate 
susceptibility. The percentage susceptibility and 
resistance of Gram-positive bacteria isolated from 
diabetic foot ulcers to antibiotics was shown in Figure 
5. Gram-positive bacteria showed 93.75% 
susceptibility, 1.21% intermediate susceptibility and 
5.01% resistance to the conventional antibiotics 
investigated in this study 
 
 
Figure 4: Percentage susceptibility and resistance of 
Gram-negative bacteria isolated from diabetic foot 
ulcers to antibiotics 
 
 
Figure 5: Percentage susceptibility and resistance of 
Gram-positive bacteria isolated from diabetic foot 
ulcers to antibiotics 
Staphylococcus aureus had the highest percentage 
occurrence, followed by P. aeruginosa among in-
patients and out-patients. Among the in-patients, 
Acinetobacter baumannii had the lowest occurrence 
while M. morganii had the lowest among the out-
patients. S. aureus remained the most predominant 
while A. baumannii had the least. This agrees with the 
results of Perim et al. [19], Ayesha [20] and Pradeep et 
al. [21]. This result deviated from the reports of 
Banashankari et al. [22] and Daniel et al. [23] who 
reported E. coli, next to staphylococci, as the 
predominant bacteria in foot ulcer. The authors 
reported some of the bacteria encountered in this 
study but in different frequency. There were a greater 
number of Gram-negative bacteria than Gram-
positive bacteria associated with diabetic foot ulcers 
and more than one potential pathogen was recovered 
from the samples analyzed in this study which is in 
agreement with some other studies [12], [24], [25].   
The antibiotic resistance profiles of S. aureus strains in 
this study were similar to the observations made by 
Joseph et al. [25]   and Oates et al. [26] in their study 
on diabetic foot infection. It, however, differs from 
the report of Daniel et al. [23] who reported 100% 
resistance of S. aureus isolates to vancomycin. 
Vancomycin resistance in Staphylococcus aureus among 
diabetic patients with foot lesion was also reported by 
Oates et al. [26]. However, different susceptibility 
patterns to antibiotics have been shown by other 
studies and, mostly, vancomycin, amikacin and 
linezolid have shown good activity against the strains 
[27] - [30], which is in agreement with findings of the 
present study. 
The challenge of antibiotic resistance is a major public 
health concern, due to its global dimension and 
alarming magnitude, although the epidemiology of 
resistance can exhibit remarkable geographical 
variability and rapid temporal evolution. The 
understanding of bacteria associated with diabetic 
foot infections (DFI) and their antibiotic 
susceptibility profiles is essential for appropriate 
treatment and infection eradication. The empirical 
initiation of antibiotic therapy in patients with serious 
infections is necessary to prevent systemic invasion by 
infecting bacteria while awaiting microbiology 
laboratory results [31].  
Clinicians should consider the results of bacterial 
culture and susceptibility testing in the light of the 
Susceptibility
76.99%
Intermediate 
Susceptibility
0.15%
Resistance
22.85%
Susceptibility
93.75%
Intermediate 
Susceptibility
1.21%
Resistance
5.01%
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clinical outcome of the infection for the empirical 
therapy regimen. Knowledge of the characteristics of 
infection, i.e., the type of bacteria commonly found 
and the clinical evidence of infections, can help in 
choosing an appropriate antibiotic, even if the culture 
reports are not available at the time of initiation of 
antibiotic therapy [32] - [33]. 
The 22.85% resistance exhibited by the bacteria 
associated with diabetic foot infection in this study is 
of medical relevance due to the possibility of 
transmitting those resistant genes to other bacteria 
sharing the same ecological niche, and thus, impairing 
the implementation of successful antibiotic therapy 
[34]. Antimicrobial resistance could be transmitted to 
the human population, hospitalized patients, and the 
hospital environment through other sources 
including animals, plant-based foods, fish, poultry, 
and other industries in which antibiotics are used for 
different purposes and may lead to emerging resistant 
strains of bacteria [35] - [37].  
The high antibiotic sensitivity profiles recorded in this 
study differ from many other studies [38] -[44], where 
bacterial strains encountered exhibited high resistance 
to most of the antibiotics investigated. This 
apparently revealed the variations in antibiotic 
sensitivity pattern of bacteria isolates based on 
geographical area. Bacterial strains, encountered in 
one geograpghical area or country are, in most cases, 
genetically different from others.  
4 Conclusions 
This study revealed that there is no definite aetiologic 
bacterial agent for diabetic foot infections and many 
of the associated bacteria are sensitive to certain 
antibiotics. Many bacteria that had been previously 
reported by many authors to be resistant to certain 
antibiotics were found to be susceptible to the 
antibiotics used in this study. Thus, many multi-drug 
resistant bacteria which could complicate the 
management of diabetic foot infections could be 
treated by the reported antibiotics. The study showed 
that many potential pathogens are associated with 
foot ulcers and which could pose serious health havoc 
if prompt therapeutic intervention is not made. This 
finding could assist clinicians to develop antibiotic 
therapy policy for the early treatment of diabetic foot 
infections in southwestern Nigeria. 
5 Declarations 
5.1 Acknowledgements 
Appreciations to the Research Ethics Committees of 
UCH, Ibadan and OOUTH, Sagamu, Nigeria for the 
permissions to obtain samples from patients visiting 
the teaching hospitals.  
5.2 Study Limitations 
There is paucity of information on factors responsible 
for prevalence of diabetic foot infection in this study. 
Further research is needed to investigate the patients’ 
attitude with respect to knowledge and practice of 
chronic wound care. In-depth information gained 
from current reports will be useful in developing risk-
assessment model for a larger prospective cohort 
study. Metagenomic analysis on whole genome 
sequences of connected tissues is necessary to 
determine the microbial diversity associated with 
diabetic foot infections. 
5.3 Ethical Approval 
Ethical approval was given by Research Ethics 
Committees of UCH, Ibadan and OOUTH, Sagamu 
to promote this research. 
5.4 Informed Consent 
Informed consent to carry out research and 
disseminate findings were obtained from participants. 
5.5 Funding Source 
None 
5.6 Competing Interests 
Author declared, no potential conflict of interest 
exists.  
How to Cite this Article 
Bello et al., “Antibiotic Susceptibility Profiles of Bacteria from 
Diabetic Foot Infections in Selected Teaching Hospitals in 
Southwestern Nigeria”, International Annals of Science, vol. 4, 
no. 1, pp. 1-13, Jan. 2018. 
References 
[1] J. Jneida, J.P. Lavigneb, B. La Scolaa and N. Cassira, ‘The 
diabetic foot microbiota: A review,” Human Microbiome 
Journal, vol. 5–6, pp. 1-6, Dec. 2017. 
[2] World Health Organization [WHO], Global Report on 
Diabetes. Geneva: April 2016.  
[3] N. R. Barshes, M. Sigireddi, J. S. Wrobel, A. Mahankhali, J. 
L. Robbins, P. Kougias and D. G. Armstrong, “The system of 
care for the diabetic foot: objectives, outcomes and 
12 
 
ISSN: 2456-7132 
Available online at Journals.aijr.in 
Antibiotic Susceptibility Profiles of Bacteria from Diabetic Foot Infections in Selected Teaching Hospitals in Southwestern Nigeria 
opportunities,” Diabetic Foot and Ankle vol. 4, p. 21847. Oct. 
2013. 
[4] R. E. Mirza, M. M. Fang, E. M. Weinheimer-Haus, W. J. Ennis 
and T. J. Koh, “Sustained inflammasome activity in 
macrophages impairs wound healing in type 2 diabetic humans 
and mice,” Diabetes, vol. 63, no. 3, pp. 1103–1114, March 
2014.  
[5] E. C. Leal, E. Carvalho, A. Tellechea, A. Kafanas, F. 
Tecilazich, C. Kearney,  S. Kuchibhotla, M. E. Auster, E. 
Kokkotou, D. J. Mooney, F. W. LoGerfo, L. Pradhan-Nabzdyk 
and A. Veves, “Substance P promotes wound healing in 
diabetes by modulating inflammation and macrophage 
phenotype,” The American Journal of Pathology, vol. 185, no. 
6, pp. 1638–1648, June 2015.  
[6] I. Hsu, L. G. Parkinson, Y. Shen, A. Toro, T. Brown, H. Zhao, 
R.C. Bleackley and D. J. Granvile, “Serpina3n accelerates 
tissue repair in a diabetic mouse model of delayed wound 
healing,” Cell Death and Disease, vol. 5, e1458, Oct 2014.  
[7] A. Spichler, B. L. Hurwitz, D. G. Armstrong and B. A. Lipsky, 
“Microbiology of diabetic foot infections: from Louis Pasteur 
to ‘crime scene investigation,’” BMC Medicine. vol. 13, p. 2, 
Jan. 2015.  
[8] J. Moura, J. Rodrigues, M. Goncalves, C. Amaral, M. Lima 
and E. Carvalho, “Impaired T-cell differentiation in diabetic 
foot ulceration,” Cellular and Molecular Immunology, vol. 14, 
pp. 758–769, March 2016.  
[9] R. D. Wolcott, J. D. Hanson, E. J. Rees, L. D. Koenig, C. D. 
Phillips, R. A. Wolcott, S. B. Cox and J.S. White, “Analysis of 
the chronic wound microbiota of 2,963 patients by 16S rDNA 
pyrosequencing,” Wound Repair Regen, vol. 24, no. 1, pp. 
163–174, Feb 2016.  
[10] K. Rahim, S. Saleha, X. Zhu, L. Huo, A. Basit, and O. L. 
Franco, “Bacterial Contribution in Chronicity of Wounds,” 
Microbial Ecology, vol. 73, no. 3, pp. 710–721, April 2017.  
[11] R.E. Pecoraro, G.E. Reiber, E.M. Burgess. “Pathways to 
diabetic limb amputation: basis for prevention,” Diabetes 
Care, vol. 13, no. 5, pp. 513-521, May 1990.  
[12] B.A. Lipsky, A.R. Berendt, P.B. Cornia, J.C. Pile, E.J.G. 
Peters, D.G. Armstrong, H.G., Deery, J.M. Embil, W.S. 
Joseph, A.W. Karchmer, M.S. Pinzur and E. Senneville. “2012 
infectious diseases society of America clinical practice 
guideline for the diagnosis and treatment of diabetic foot 
infections,” Clinical Infectious Diseases, vol. 54, no. 12, e132 
- e173, June. 2012. 
[13] A. Icks, M. Scheer, E. Morbach, J. Genz, B. Haastert, G. Giani, 
G. Glaeske and F. Hoffman, “Time-dependent impact of 
diabetes on mortality in patients after major lower extremity 
amputation.” Diabetes Care, vol. 34, pp. 1350–1354, June 
2011.  
[14] M. Kerr, “Foot Care for People with Diabetes: The Economic 
Case for Change,” NHS Diabetes, 2012-03. Available at: 
http://www.diabetes.org.uk/Documents/nhs-
diabetes/footcare/footcare-for-people-with-diabetes.pdf 
[accessed July 19,2017]. 
[15] A. Banu, M. M. NoorulHassan, J. Rajkumar, and S. Srinivasa, 
“Spectrum of bacteria associated with diabetic foot ulcer and 
biofilm formation: a prospective study,” The Australasian 
Medical Journal, vol. 8, no. 9, pp. 280–285, Sept 2015.  
[16] R. Santos, A.S. Veiga, L. Tavares, M. Castanho and M. 
Oliveira,  “Bacterial biofilms in diabetic foot ulcers: potential 
alternative therapeutics”, in Microbial Biofilms – Importance 
and Applications, ed. D. Dhanasekaran and N. Thajuddin 
(Rijeka: InTech Press), July 2016. pp. 251–269. 
[17] M. Cheesbrough. District laboratory practice in tropical 
countries. part 2, 2nd ed. UK: Cambridge University, 2006, p. 
35–197. 
[18] CLSI (Clinical Laboratory Standards Institute), “Performance 
standards for antimicrobial susceptibility testing” NCCLS 
approved standard M100-S14, Wayne, PA. USA, II (2), 2016, 
pp. 298-102. 
[19] M. C. Perim, J. C. Borges, S. R. C. Celeste, E. F. Orsolin, R. 
R. Mendes, G. O. Mendes, R. L. Ferreira, S.C. Carreiro, and 
M.C. Pranchevicius, “Aerobic bacterial profile and antibiotic 
resistance in patients with diabetic foot infections,” Revista da 
Sociedade Brasileira de Medicina Tropical, vol. 48, no. 5, 
Sept/Oct 2015.   
[20] A. Nageen, “The Most Prevalent Organism in Diabetic Foot 
Ulcers and Its Drug Sensitivity and Resistance to Different 
Standard Antibiotics,” Journal of the College of Physicians 
and Surgeons Pakistan, vol. 26, no. 4, pp. 293-296, Dec 2016.  
[21] M. S. S. Pradeep, K. Vishnuvardhanarao and C. R. Setty, 
“Bacteriological profile and their Antibiotic Sensitivity Pattern 
in Diabetic Foot Infections in a Tertiary Care Hospital,” 
Scholars Journal of Applied Medical Sciences, vol. 5, no. 5C, 
pp. 1883-1887, May 2017.  
[22] G.S. Banashankari, H.K. Rudresh and A.H. Harsha. 
“Prevalence of Gram Negative Bacteria in Diabetic Foot-A 
Clinico-Microbiological Study,” Al-Ameen Journal of Medical 
Sciences, vol. 5, no. 3, pp. 224 -232, Sept. 2012. 
[23] S.J.C. Daniel, E. Gowthami and S. Sowmiya, “Isolation and 
identification of bacterial pathogens from wounds of diabetic 
patients,” International Journal of Current 
Microbiology and Applied Sciences, vol. 2, no. 11, pp. 72-77, 
2013. 
[24] Z. Mohammad, M. Abida and A. Jamal. “Clinico-bacteriology 
and risk factors for the diabetic foot infection with multidrug 
resistant microorganisms in north India.” Biology and 
Medicine, vol. 2, no. 4, pp. 22-34, 2010.  
[25] K. Joseph, A. T. George, M. B. Divya and K. K. Ameena, 
“Diabetic foot infections: characterization and antibiotic 
resistance pattern of aerobic bacterial isolates in a tertiary care 
hospital of North Kerala.”  International Journal of Current 
Microbiology and Applied Sciences, vol. 6, no. 9, pp. 3493-
3499, Sept 2017.  
[26] A. Oates, L. Frank, J.M.B. Andrew, M. Boulton -Citron, J. 
Ellie, C. Goldstein, C. Vreni- Merriam, A.B. Lipsky and A. 
Murray. “Bacteriology of moderate-to-severe diabetic foot 
infections and In vitro activity of antimicrobial agents,” 
Journal of Clinical Microbiology, vol. 45, no. 9, pp. 2819-
2828, July 2007.   
[27] M. Anvarinejad, G. Pouladfar, A. Japoni, S. Bolandparvaz, Z. 
Satiary and J. Mardaneh, “Diabetic Foot Infections: antibiotic 
susceptibility patterns and determination of antibiotic cross-
resistance in clinical isolates of Enterococcus species during 
2012 - 2014 in Shiraz, Iran,” Arch Pediatr Infect Dis., vol. 5, 
no. 2, e37680, April 2017. 
[28] E. J. Peters, B. A. Lipsky, J. Aragon-Sanchez, E. J. Boyko, M. 
Diggle, J. M. Embil, S. Kono, L. A. Lavery, E. Senneville, V. 
Urbancic-Rovan, S. A. Van Asten and W. J. Jeffocate, 
“Interventions in the management of infection in the foot in 
diabetes: a systematic review.” Diabetes Metabolism Research 
and Review, vol. 32, no. 1, pp. 145–53, Jan 2016.  
[29] M. T. Akhi, R. Ghotaslou, M. Asgharzadeh, M. Varshochi, T. 
Pirzadeh, M. Y. Memar, A. Z. Bialvaei, H. S. Y. Sofla and N. 
Alizadeh  “Bacterial etiology and antibiotic susceptibility 
pattern of diabetic foot infections in Tabriz, Iran,” GMS 
Hygiene and Infection Control, vol. 10, no. 2, Feb 2015. 
[30] T. G. D. Pemayun, and R. M. Naibaho, “Clinical profile and 
outcome of diabetic foot ulcer, a view from tertiary care 
hospital in Semarang, Indonesia.” Diabetic Foot and Ankle, 
vol. 8, no. 1, p. 1312974, May 2017. 
13 
 
ISSN: 2456-7132 
Available online at Journals.aijr.in 
Bello et al., Int. Ann. Sci.; Vol. 4 Issue 1, pp: 1-13, 2018 
[31] S. V. Patil and R. R. Mane. Bacterial and clinical profile of 
diabetic foot ulcer using optimal culture techniques.  
International Journal of Research in Medical Sciences, vol. 5, 
no. 2, pp. 496-502, Feb 2017.  
[32] A. Karakus, M. Ozkan, M. Karcioglu, R. Ozden, I. Ustun, K. 
Caliskan, C. Gokce and M. Sahan, “Diabetic foot due to 
anaphylactic shock: a case report.” Archives of Trauma 
Research, vol. 3, no. 2, e17610, June 2014.  
[33] B. Poorabbas, J. Mardaneh, Z. Rezaei, M. Kalani, G. 
Pouladfar, M. H. Alami, J. Soltani, A. Shamsi-Zadeh, S. 
Abdoli-Oskooi, M. J. Saffar and A. Alborzi, “Nosocomial 
Infections: Multicenter surveillance of antimicrobial resistance 
profile of Staphylococcus aureus and Gram negative rods 
isolated from blood and other sterile body fluids in Iran.”  
Iranian Journal of Microbiology, vol. 7, no. 3, pp. 127–35, 
June 2015. 
[34] T. Semedo-Lemsaddek, C. Mottola, C. Alves-Barroco, P. 
Cavaco-Silva, L. Tavares, M. Oliveira, “Characterization of 
multidrug-resistant diabetic foot ulcer enterococci.” 
Enfermedades Infecciosas y Microbiologia Clinica, vol. 34, 
no. 2, pp. 114–116, Feb 2015. 
[35] J. Mardaneh, and M. M. Soltan-Dallal, “Isolation and 
identification of E. cowanii from powdered infant formula in 
NICU and determination of antimicrobial susceptibility of 
isolates. Iranian Journal of Pediatrics, vol. 24, no. 3, pp. 261–
266, June 2014. 
[36] J. Soltani, B. Poorabbas, N. Miri, and J. Mardaneh, “Health 
care associated infections, antibiotic resistance and clinical 
outcome: A surveillance study from Sanandaj, Iran.” World 
Journal of Clinical Cases, vol. 4, no. 3, pp. 63–70, March 
2016.  
[37] O.O. Bello, H.O. Egberongbe, T.O. Adesetan and A.M. 
Adenekan, “Antibiotic sensitivity profiles of bacteria isolated 
from decayed teeth,” Scholars Academic Journal of 
Pharmacy, vol.  2, no. 6, pp. 424-428, Nov 2013. 
[38] S. Chang, D.M. Sievert, J.C. Hageman, M.L. Boulton, F.C. 
Tenover, F.P. Downes, S. Shah, J.T. Rudrik, G.R. Pupp, W.J. 
Brown, D. Cardo and S.K. Fridkin. “Infection with 
vancomycin-resistant Staphylococcus aureus containing the 
vanA resistance gene.” New England Journal of Medicine, vol. 
348, no. 14, pp. 1342 1347, Apr. 2003.  
[39] A. F. de Oliveira and H. D. Oliveira Filho, “Microbiological 
species and antimicrobial resistance profile in patients with 
diabetic foot infections,” Jornal Vascular Brasileiro, vol. 13, 
no. 4, pp. 289–293, Dec 2014. 
[40] M.F.P. Raymundo, and M.T. Mendoza, “The microbiological 
features and clinical outcome of diabetic foot infections among 
patients admitted at UP-PGH.” Phillipines Journal of 
Microbiology and Infectious Diseases, vol. 31, pp. 51-63, 
2002.  
[41] N. Singh, D.G. Armstrong and B.A. Lipsky, “Preventing foot 
ulcers in patients with diabetes.” The Journal of the American 
Medical Association,  vol. 293, no. 2, pp. 217-28, Jan. 2005.  
[42] W.J. Jeffcoate, B.A. Lipsky, A.R. Berendt, P.R. Cavanagh, 
S.A. Bus, E.J. Peters, W.H. van Houtum, G.D. Valk and K. 
Bakker, “Unresolved issues in the management of ulcers of the 
foot in diabetes.” Diabetic Medicine, vol. 25, vol. 12, pp.1380-
1389, Jan 2009.   
[43] B. M. Pabithadevi, V. K. Rajendran and M. Sadana, “Clinical 
Outcomes of Diabetic Foot and Its Management,” IOSR 
Journal of Dental and Medical Sciences, vol. 15, no. 1, pp. 10-
15, Jan 2016.    
[44] X. Xie, Y. Bao, L. Ni, D. Liu, S. Niu, H. Lin, H. Li, C. Duan, 
L. Yan, S. Huang and Z. Luo, “Bacterial profile and antibiotic 
resistance in patients with diabetic foot ulcer in Guangzhou, 
Southern China: focus on the differences among different 
Wagner’s Grades, IDSA/IWGDF grades, and ulcer types. 
International Journal of Endocrinology, vol. 2017, Article ID 
8694903, pp. 1 – 12, July 2017. 
Publish your research article in AIJR journals- 
✓ Online Submission and Tracking 
✓ Peer-Reviewed 
✓ Rapid decision 
✓ Immediate Publication after acceptance 
✓ Articles freely available online 
✓ Retain full copyright of your article. 
Submit your article at journals.aijr.in  
Publish your books with AIJR publisher- 
✓ Publish with ISBN and DOI. 
✓ Publish Thesis/Dissertation as a Book. 
✓ Publish Monograph. 
✓ Publish Edited Volume/ Book. 
✓ Publish Conference Proceedings 
✓ Retain full copyright of your books. 
Submit your manuscript at books.aijr.org 
